- $264.90m
- $241.92m
- $255.62m
Annual cashflow statement for Citizens, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 36.8 | -6.64 | 24.4 | 14.9 | 14.6 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.85 | 15 | 4.77 | 9.26 | 7.07 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.95 | 46.9 | -9.13 | 8.33 | -6.33 |
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Change in Deferred Policy Acquisition Costs | |||||
| Change in Reinsurance Receivable | |||||
| Change in Insurance Reserves | |||||
| Cash from Operating Activities | 40.5 | 56.9 | 22.1 | 31.9 | 18 |
| Capital Expenditures | -1.01 | -0.1 | -0.442 | -0.663 | -0.447 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -40.1 | -60.6 | -14.1 | -26.5 | -19.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -41.1 | -60.7 | -14.5 | -27.2 | -19.7 |
| Financing Cash Flow Items | 1.08 | 0.08 | -2.56 | -2.08 | -4.33 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -6.21 | -0.499 | -3.54 | -2.47 | -4.61 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.84 | -4.32 | 4.02 | 2.27 | -6.29 |